Clinical Trial Update: Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating nicotine nasal spray for smoking cessation in schizophrenia has completed. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Tobacco Use Disorder

Drugs mentioned

• Nicotrol NS (nicotine nasal spray)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Smoking Cessation, Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2014-09-08